Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Tilray Inc    TLRY

TILRAY INC (TLRY)
My previous session
Most popular
  Report  
 SummaryQuotesChartsNewsCompany 
OFFRE
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/19/2018 09/20/2018 09/21/2018 09/24/2018 09/25/2018 Date
214.06(c) 176.35(c) 123(c) 99.5(c) 107.88(c) Last
31 717 724 20 493 545 16 097 705 12 388 846 8 922 359 Volume
+38.12% -17.62% -30.25% -19.11% +8.42% Change
More quotes
Company
Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids.Its products include dried cannabis and cannabis extracts.The company was founded on January 24, 2018 and is headquartered in Nanaimo, Canada. 
Sector
Pharmaceuticals
Calendar
-
More about the company
Latest news on TILRAY INC
02:16aTILRAY : Impact on Cannabis Market Volatility, According to Analysts
AQ
09/25TODAY’S RESEARCH REPORTS ON STOCKS T : Intrexon and Tilray
AC
09/25ENWAVE CORPORATION : - ceo's message to stakeholders
AQ
09/24TILRAY : Unmitigated Disaster for Speculators
AQ
09/23CANNABIS WEEKLY ROUND-UP : Tilray Drives Up the Market
AQ
09/21CANNABIS WEEKLY ROUND-UP : Tilray Drives Up the Market
AQ
09/21TILRAY : 420 with CNW – UC San Diego Researchers to Study Effect of Cannab..
AQ
09/21FRIDAY SECTOR LAGGARDS : Biotechnology, Precious Metals
AQ
09/21TILRAY, INC.’S (NASDAQ : TLRY) Status as Global Pioneer in Cannabis Produc..
AQ
09/21INTELGENX TECHNOLOGIES : Signs Letter of Intent with Tilray to Enter Into a Worl..
AQ
More news
Sector news : Pharmaceuticals - NEC
08:15aSHIRE PLC SHIRE PLC : Rule 2.9 Announcement
DJ
09/25EUROPE : Oil boost and Italy budget hopes support European shares
RE
09/25ASTRAZENECA : Positive Data Bolsters Case For AstraZeneca's Imfinzi -- Update
DJ
09/25ASTRAZENECA : Data Show Cancer Drug Imfinzi Reduces Death Risk
DJ
09/25NOVARTIS : to Cut 2,000 Jobs Amid Revamp -- 2nd Update
DJ
More sector news : Pharmaceuticals - NEC
Latest Tweets
07:47aShort-seller Tilson says Tilray 'will be a case study for years'. $TLRY  
06:03aTilray, how low can it go?
1
06:03aTilray, how low can it go?  
06:03aTilray, how low can it go?
3
06:01aTilray, how low can it go?  
More tweets
Qtime:18
News from SeekingAlpha
09/25AURORA CANNABIS : Wow! That Was An Impressive Quarter 
09/25Midday Gainers / Losers (09/25/2018) 
09/25Bet Against Tilray As The Stock Heads Sharply Lower 
09/25CRONOS : The Time To Sell Is Now 
09/25HEALTHCARE - TOP 5 GAINERS / LOSERS : 00 am (09/25/2018) 
Chart TILRAY INC
Duration : Period :
Tilray Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends TILRAY INC
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Managers
NameTitle
Brendan Kennedy President, Chief Executive Officer & Director
Mark Castaneda Chief Financial Officer, Secretary & Treasurer
Joshua Eades Chief Science Officer & Vice President
Christine Thompson St. Clare Independent Director
Maryscott Greenwood Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
TILRAY INC0.00%9 268
JOHNSON & JOHNSON2.26%376 847
PFIZER20.90%257 522
NOVARTIS-0.63%217 697
ROCHE HOLDING LTD.-5.48%209 212
MERCK AND COMPANY25.79%188 241